Molecular Biology Reports

, Volume 45, Issue 4, pp 445–451 | Cite as

Expression pattern of cdkl5 during zebrafish early development: implications for use as model for atypical Rett syndrome

  • Marta Vitorino
  • Nídia Cunha
  • Natércia Conceição
  • M. Leonor Cancela
Original Article


Atypical Rett syndrome is a child neurodevelopmental disorder induced by mutations in CDKL5 gene and characterized by a progressive regression in development with loss of purposeful use of the hands, slowed brain and head growth, problems with walking, seizures, and intellectual disability. At the moment, there is no cure for this pathology and little information is available concerning animal models capable of mimicking its phenotypes, thus the development of additional animal models should be of interest to gain more knowledge about the disease. Zebrafish has been used successfully as model organism for many human genetic diseases; however, no information is available concerning the spatial and temporal expression of cdkl5 orthologous in this organism. In the present study, we identified the developmental expression patterns of cdkl5 in zebrafish by quantitative PCR and whole-mount in situ hybridization. cdkl5 is expressed maternally at low levels during the first 24 h of development. After that the expression of the gene increases significantly and it starts to be expressed mainly in the nervous system and in several brain structures, such as telencephalon, mesencephalon and diencephalon. The expression patterns of cdkl5 in zebrafish is in accordance with the tissues known to be affected in humans and associated to symptoms and deficits observed in Rett syndrome patients thus providing the first evidence that zebrafish could be an alternative model to study the molecular pathways of this disease as well as to test possible therapeutic approaches capable of rescuing the phenotype.


Cdkl5 Zebrafish Brain Rett syndrome 



This research was partially supported by national funds from FCT - Foundation for Science and Technology through project UID/Multi/04326/2013. MV was supported by a postdoctoral fellowship reference SFRH/BPD/65923/2009 from the Portuguese Foundation for Science and Technology (FCT).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All experimental procedures involving animals followed the European Directive 2010/63/EU and the related guidelines (European Commission, 2014) and Portuguese legislation (Decreto-Lei 113/2013 and Despacho 2880/2015) for animal experimentation and welfare.


  1. 1.
    Moretti P, Zoghbi HY (2006) MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev 16(3):276–281. CrossRefPubMedGoogle Scholar
  2. 2.
    Wang ITJ, Allen M, Goffin D, Zhu X, Fairless AH, Brodkin ES, Siegel SJ, Marsh ED, Blendy JA, Zhou Z (2012) Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. Proc Natl Acad Sci USA 109(52):21516–21521. CrossRefPubMedGoogle Scholar
  3. 3.
    Amendola E, Zhan Y, Mattucci C, Castroflorio E, Calcagno E, Fuchs C, Lonetti G, Silingardi D, Vyssotski AL, Farley D, Ciani E, Pizzorusso T, Giustetto M, Gross CT (2014) Mapping pathological phenotypes in a mouse model of CDKL5 disorder. PLoS ONE 9(5):e91613. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Okuda K, Kobayashi S, Fukaya M, Watanabe A, Murakami T, Hagiwara M, Sato T, Ueno H, Ogonuki N, Komano-Inoue S, Manabe H, Yamaguchi M, Ogura A, Asahara H, Sakagami H, Mizuguchi M, Manabe T, Tanaka T (2017) CDKL5 controls postsynaptic localization of GluN2B-containing NMDA receptors in the hippocampus and regulates seizure susceptibility. Neurobiol Dis 106(Supplement C):158–170. CrossRefPubMedGoogle Scholar
  5. 5.
    Dooley K, Zon LI (2000) Zebrafish: a model system for the study of human disease. Curr Opin Genet Dev 10(3):252–256. CrossRefPubMedGoogle Scholar
  6. 6.
    Lieschke GJ, Currie PD (2007) Animal models of human disease: zebrafish swim into view. Nat Rev Genet 8(5):353–367. CrossRefPubMedGoogle Scholar
  7. 7.
    Khan KM, Collier AD, Meshalkina DA, Kysil EV, Khatsko SL, Kolesnikova T, Morzherin YY, Warnick JE, Kalueff AV, Echevarria DJ (2017) Zebrafish models in neuropsychopharmacology and CNS drug discovery. Br J Pharmacol 174(13):1925–1944. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Amar A (2017) Commentary: zebrafish as a model for epilepsy-induced cognitive dysfunction: a pharmacological, biochemical and behavioral approach. Front Pharmacol 8:851. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Yun-Zhu P, Liang L, Ai-Ling F, Yan L, Lan S, Qian L, Dan W, Man-Ji S, Ying-Ge Z, Bao-Quan Z (2017) Generation of alzheimer’s disease transgenic zebrafish expressing human APP mutation under control of zebrafish appb promotor. Curr Alzheimer Res 14(6):668–679. CrossRefGoogle Scholar
  10. 10.
    Matsui H, Takahashi R (2017) Parkinson’s disease pathogenesis from the viewpoint of small fish models. J Neural Transm. CrossRefPubMedGoogle Scholar
  11. 11.
    Giacomotto J, Carroll AP, Rinkwitz S, Mowry B, Cairns MJ, Becker TS (2016) Developmental suppression of schizophrenia-associated miR-137 alters sensorimotor function in zebrafish. Transl Psychiatry 6(5):e818. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Marcon M, Herrmann AP, Mocelin R, Rambo CL, Koakoski G, Abreu MS, Conterato GMM, Kist LW, Bogo MR, Zanatta L, Barcellos LJG, Piato AL (2016) Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline. Psychopharmacology 233(21):3815–3824. CrossRefPubMedGoogle Scholar
  13. 13.
    Gerlai R (2015) Embryonic alcohol exposure: towards the development of a zebrafish model of fetal alcohol spectrum disorders. Dev Psychobiol 57(7):787–798. CrossRefPubMedGoogle Scholar
  14. 14.
    Hanks SK, Quinn AM, Hunter T (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241(4861):42–52. CrossRefPubMedGoogle Scholar
  15. 15.
    Manning G, Plowman GD, Hunter T, Sudarsanam S (2002) Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci 27(10):514–520. CrossRefPubMedGoogle Scholar
  16. 16.
    Chatonnet F, Thoby-Brisson M, Abadie V, Domínguez del Toro E, Champagnat J, Fortin G (2002) Early development of respiratory rhythm generation in mouse and chick. Respir Physiol Neurobiol 131(1–2):5–13. CrossRefPubMedGoogle Scholar
  17. 17.
    Nozaki S, Iriki A, Nakamura Y (1986) Localization of central rhythm generator involved in cortically induced rhythmical masticatory jaw-opening movement in the guinea pig. J Neurophysiol 55(4):806–825. CrossRefPubMedGoogle Scholar
  18. 18.
    Breedlove SM, Watson NV, Rosenzweig MR (2010) Biological psychology: an introduction to behavioral, cognitive, and clinical neuroscience. 6th edn, Sinauer Associates, Inc., SunderlandGoogle Scholar
  19. 19.
    Wray S, Fueshko SM, Kusano K, Gainer H (1996) GABAergic neurons in the embryonic olfactory pit/vomeronasal organ: maintenance of functional GABAergic synapses in olfactory explants. Dev Biol 180(2):631–645. CrossRefPubMedGoogle Scholar
  20. 20.
    Hemsley KM, Crocker AD (2001) Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the Ventral striatum and D1 receptors in the substantia Nigra. Neuropsychopharmacology 25(4):514–526. CrossRefPubMedGoogle Scholar
  21. 21.
    Arnould-taylor WE (1998) A textbook of anatomy and physiology. 3rd edn, Stanley Thornes, Ltd., CheltenhamGoogle Scholar
  22. 22.
    Hector RD, Dando O, Landsberger N, Kilstrup-Nielsen C, Kind PC, Bailey MES, Cobb SR (2016) Characterisation of CDKL5 transcript isoforms in human and mouse. PLoS ONE 11(6):e0157758. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Bahi-Buisson N, Nectoux J, Rosas-Vargas H, Milh M, Boddaert N, Girard B, Cances C, Ville D, Afenjar A, Rio M, Héron D, N’Guyen Morel MA, Arzimanoglou A, Philippe C, Jonveaux P, Chelly J, Bienvenu T (2008) Key clinical features to identify girls with CDKL5 mutations. Brain 131(10):2647–2661. CrossRefPubMedGoogle Scholar
  24. 24.
    Krishnaraj R, Ho G, Christodoulou J (2017) RettBASE: Rett syndrome database update. Hum Mutat 38(8):922–931. CrossRefPubMedGoogle Scholar
  25. 25.
    Evans JC, Archer HL, Colley JP, Ravn K, Nielsen JB, Kerr A, Williams E, Christodoulou J, Gécz J, Jardine PE, Wright MJ, Pilz DT, Lazarou L, Cooper DN, Sampson JR, Butler R, Whatley SD, Clarke AJ (2005) Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 13:1113.
  26. 26.
    Fehr S, Downs J, Ho G, de Klerk N, Forbes D, Christodoulou J, Williams S, Leonard H (2016) Functional abilities in children and adults with the CDKL5 disorder. Am J Med Genet A 170(11):2860–2869. CrossRefPubMedGoogle Scholar
  27. 27.
    Archer HL, Evans J, Edwards S, Colley J, Newbury-Ecob R, O’Callaghan F, Huyton M, O’Regan M, Tolmie J, Sampson J, Clarke A, Osborne J (2006) CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet 43(9):729–734. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203(3):253–310. CrossRefPubMedGoogle Scholar
  29. 29.
    Thisse C, Thisse B (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3(1):59–69. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Center of Marine Sciences (CCMAR)University of AlgarveFaroPortugal
  2. 2.Department of Biomedical Sciences and MedicineUniversity of AlgarveFaroPortugal
  3. 3.Algarve Biomedical CenterFaroPortugal

Personalised recommendations